TrialThe New England journal of medicine2018
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC.
Mark A Socinski et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2,194 papers cite itlatest 60 shown
this paperpooled ittrialcites it